MaxCyte Inc (MXCT) support and resistance · rev $38.6M
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
This page maps MaxCyte Inc (MXCT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
MXCT currently screens at market cap $124.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MXCT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MXCT quote page for the session range and the stock page for the full model.
Not investment advice.